Patents Assigned to GenScript USA Inc.
  • Patent number: 11898186
    Abstract: A method for in vitro transcription of a DNA template into RNA includes providing a mixture containing a buffer substance, ribonucleoside triphosphates (NTPs), one or more magnesium salts in a concentration of from about 2 mM to about 60 mM, the DNA template, and a recombinant RNA polymerase, and incubating the reaction mixture at from about 25° C. to about 40° C. for from about 1 hour to about 12 hours thereby producing the RNA. A method for in vitro transcription includes providing a DNA template and a cap analogue that binds to ?1 and/or +1 nucleotides of promoter for in vitro transcription, thus producing more full length mRNAs, allowing for more flexibility on the choice of first mRNA base, and providing +2 position open for custom sequence.
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: February 13, 2024
    Assignee: GENSCRIPT USA INC.
    Inventors: Cheng-Hsien Wu, Fengmei Pi, Robert Dempcy, Shambhavi Shubham, Kristine Bielecki, Aaron Ball
  • Publication number: 20230332134
    Abstract: Provided is an automated system for preparing purified plasmid DNA in commercial scale.
    Type: Application
    Filed: August 17, 2021
    Publication date: October 19, 2023
    Applicants: Nanjing GenScript Biotech Co., Ltd., GenScript USA Inc.
    Inventors: Stephen Richard Hughes, Xiaoli Fu, Yifan Li, Yuzhuo He, Hong Li, Cheng-Hsien Wu, Chuan Sun